Skip to main content

Alkermes

Alkermes plc is an Irish biopharmaceutical company focusing on neuroscience therapeutics for complex central nervous system and psychiatric disorders. The company develops and commercializes proprietary medicines, including Vivitrol for alcohol and opioid dependence, Aristada for schizophrenia, and Lybalvi for bipolar I disorder. Main revenue drivers stem from commercial sales of branded proprietary neuroscience therapies alongside manufacturing fees and royalty revenues from licensed partner products. Alkermes serves psychiatrists, addiction medicine specialists, hospital healthcare networks, and patients across the United States and international markets. The company maintains an established market position in central nervous system disorder therapeutics. Headquartered in Dublin, Ireland, Alkermes plc is listed on the Nasdaq Stock Market.

11 of the funds FundTelligence covers report a position in Alkermes.

Legal name
Alkermes PLC
Sector
Health Care
Country
Ireland
Funds holding it
11
Exposure themes
Addiction, Mental Health, Psychiatry, Schizophrenia & Psychosis

Funds holding Alkermes

Showing the 8 largest of 11 funds holding it.

Loading...